Literature DB >> 1321309

Adrenocorticotrophin and steroid-induced hypertension in humans.

J A Whitworth1.   

Abstract

ACTH and adrenocortical steroids have been known to raise blood pressure since their introduction into clinical practice. Our experimental studies in normal subjects show that ACTH reproducibly increases blood pressure in association with a rise in cardiac output, plasma and extracellular fluid volumes and exchangeable sodium. The rise in pressure is adrenally dependent and appears due to ACTH-induced increases in cortisol secretion. When ACTH is given by constant intravenous infusion, rates as low as 50 micrograms/day raise pressure. The increase in blood pressure is not dependent on, but modified by, dietary sodium content. Synthetic steroids (prednisolone, methylprednisolone, triamcinolone, dexamethasone) raise pressure in the absence of any increase in plasma volume or urinary sodium retention. Cortisol increases pressor responsiveness to endogenous and exogenous catecholamines, without evidence of any increase in sympathetic nervous activity. The role of this increased pressor responsiveness in ACTH/steroid-induced hypertension remains to be determined. There is some evidence from human studies that steroids may raise pressure by a hypertensinogenic mechanism, distinct from classical mineralocorticoid or glucocorticoid effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321309

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  7 in total

Review 1.  Clinical Relevance of Steroid Use in Neuro-Oncology.

Authors:  K Ina Ly; Patrick Y Wen
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

2.  Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease.

Authors:  Jeremy Adler; Scott D Swanson; Phyllissa Schmiedlin-Ren; Peter D R Higgins; Christopher P Golembeski; Alexandros D Polydorides; Barbara J McKenna; Hero K Hussain; Trevor M Verrot; Ellen M Zimmermann
Journal:  Radiology       Date:  2011-01-28       Impact factor: 11.105

3.  Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss : Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT).

Authors:  Stefan K Plontke; Matthias Girndt; Christoph Meisner; Iris Böselt; Beatrice Ludwig-Kraus; Michael Richter; Torsten Rahne
Journal:  HNO       Date:  2022-06-20       Impact factor: 1.330

4.  Ultrasonography as a predictor of overt bleeding after renal biopsy.

Authors:  Eiji Ishikawa; Shinsuke Nomura; Tomiya Hamaguchi; Toshihide Obe; Michiyo Inoue-Kiyohara; Kazuki Oosugi; Kan Katayama; Masaaki Ito
Journal:  Clin Exp Nephrol       Date:  2009-04-21       Impact factor: 2.801

5.  Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Authors:  Melpomeni Peppa; Maria Krania; Sotirios A Raptis
Journal:  Integr Blood Press Control       Date:  2011-03-03

6.  Effects of 6-month sitagliptin treatment on metabolic parameters in diabetic patients taking oral glucocorticoids: a retrospective cohort study.

Authors:  Hisayuki Katsuyama; Akahito Sako; Hiroki Adachi; Hidetaka Hamasaki; Hidekatsu Yanai
Journal:  J Clin Med Res       Date:  2015-04-08

Review 7.  Immunomodulatory Potential of Diuretics.

Authors:  Paweł Bryniarski; Katarzyna Nazimek; Janusz Marcinkiewicz
Journal:  Biology (Basel)       Date:  2021-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.